BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22695065)

  • 1. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials.
    Arciola CR; Campoccia D; Speziale P; Montanaro L; Costerton JW
    Biomaterials; 2012 Sep; 33(26):5967-82. PubMed ID: 22695065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides and staphylococcal biofilms.
    Parra-Ruiz J; Vidaillac C; Rybak MJ
    Rev Esp Quimioter; 2012 Mar; 25(1):10-6. PubMed ID: 22488536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Analyses on Data including Essential Oil Chemical Composition and In Vitro Experimental Antibiofilm Activities against
    Patsilinakos A; Artini M; Papa R; Sabatino M; Božović M; Garzoli S; Vrenna G; Buzzi R; Manfredini S; Selan L; Ragno R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?
    Otto M
    FEMS Microbiol Lett; 2004 Dec; 241(2):135-41. PubMed ID: 15598524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition.
    Chaignon P; Sadovskaya I; Ragunah Ch; Ramasubbu N; Kaplan JB; Jabbouri S
    Appl Microbiol Biotechnol; 2007 May; 75(1):125-32. PubMed ID: 17221196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection.
    Frei E; Hodgkiss-Harlow K; Rossi PJ; Edmiston CE; Bandyk DF
    Vasc Endovascular Surg; 2011 Nov; 45(8):688-96. PubMed ID: 21921082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus quorum sensing in biofilm formation and infection.
    Kong KF; Vuong C; Otto M
    Int J Med Microbiol; 2006 Apr; 296(2-3):133-9. PubMed ID: 16487744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BioTimer Assay, a new method for counting Staphylococcus spp. in biofilm without sample manipulation applied to evaluate antibiotic susceptibility of biofilm.
    Pantanella F; Valenti P; Frioni A; Natalizi T; Coltella L; Berlutti F
    J Microbiol Methods; 2008 Dec; 75(3):478-84. PubMed ID: 18721833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci.
    Frank KL; Patel R
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):9-16. PubMed ID: 17889481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
    Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
    J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accessory gene regulator in Staphylococcus biofilm formation and infection].
    Tang JN; Zhou R; Wang HN; Zeng ZG
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1066-70. PubMed ID: 19060379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection?
    Fitzpatrick F; Humphreys H; O'Gara JP
    Clin Microbiol Infect; 2005 Dec; 11(12):967-73. PubMed ID: 16307550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vancomycin-coated tympanostomy tubes on methicillin-resistant Staphylococcus aureus biofilm formation: in vitro study.
    Jang CH; Park H; Cho YB; Choi CH
    J Laryngol Otol; 2010 Jun; 124(6):594-8. PubMed ID: 20056010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain.
    Pompilio A; De Nicola S; Crocetta V; Guarnieri S; Savini V; Carretto E; Di Bonaventura G
    BMC Microbiol; 2015 May; 15():109. PubMed ID: 25994406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
    van Heerden J; Turner M; Hoffmann D; Moolman J
    J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?
    Brady AJ; Laverty G; Gilpin DF; Kearney P; Tunney M
    J Med Microbiol; 2017 Apr; 66(4):461-469. PubMed ID: 28463662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm formation by staphylococci in health-related environments and recent reports on their control using natural compounds.
    Yong YY; Dykes GA; Choo WS
    Crit Rev Microbiol; 2019 Mar; 45(2):201-222. PubMed ID: 30786799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the biomaterials technologies for infection-resistant surfaces.
    Campoccia D; Montanaro L; Arciola CR
    Biomaterials; 2013 Nov; 34(34):8533-54. PubMed ID: 23953781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections.
    Arciola CR; Campoccia D; Gamberini S; Donati ME; Pirini V; Visai L; Speziale P; Montanaro L
    Biomaterials; 2005 Nov; 26(33):6530-5. PubMed ID: 15949842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submicron-textured biomaterial surface reduces staphylococcal bacterial adhesion and biofilm formation.
    Xu LC; Siedlecki CA
    Acta Biomater; 2012 Jan; 8(1):72-81. PubMed ID: 21884831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.